C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2011
11/24/2011	US20110287477 Protein concentrates and isolates, and processes for the production thereof from toasted oilseed meal
11/24/2011	US20110287454 Methods for monoclonal antibody production
11/24/2011	US20110287443 High level expression of recombinant toxin proteins
11/24/2011	US20110287071 Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
11/24/2011	US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011	US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods
11/24/2011	US20110287032 Novel ctla4-ig immunoadhesins
11/24/2011	US20110287021 Neoplasm specific antibodies and uses thereof
11/24/2011	US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same
11/24/2011	US20110287010 Diagnostic methods and markers
11/24/2011	US20110287009 Production of Heteromultimeric Proteins
11/24/2011	CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo
11/23/2011	EP2388323A2 Humanized anti-9 integrin antibodies and the uses thereof
11/23/2011	EP2388321A1 Novel expression vector
11/23/2011	EP2388320A1 Anti-hs6st2 antibody and use thereof
11/23/2011	EP2388275A2 An aglycosylated IgG1 antibody to CD3
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP1578903B1 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1507787B1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/23/2011	EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011	CN1618801B D-aminoacylase mutants
11/23/2011	CN102257139A Process for producing protein capable of forming inclusion body
11/23/2011	CN102251006A Method for manufacturing collagen from black sea cucumbers from East China Sea
11/23/2011	CN102251005A Preparation method of royal jelly polypeptide
11/23/2011	CN102251004A Preparation method of royal jelly polypeptide
11/23/2011	CN102251003A Preparation technique of marine-organism-derived antihypertensive peptides
11/23/2011	CN102251002A Method for preparing antioxidant polypeptide by solid fermentation of acanthogobius hasta muscle protein
11/23/2011	CN102251001A Preparation method of vegetable protein antioxidant
11/23/2011	CN102251000A Preparation method of compound bioactive peptide
11/23/2011	CN102250999A Separating and purifying method of peanut bioactive peptide
11/23/2011	CN102250998A Preparation method for peanut bioactive peptide
11/23/2011	CN102250997A Active peptide preparation method by hydrolyzing oyster protein with composite enzyme
11/23/2011	CN102250996A Method for deodorizing fish peptide
11/23/2011	CN102250995A Method for degumming from silk spinning raw material and recovering sericin
11/23/2011	CN102250994A Method for preparing angiotensin I-converting enzyme inhibitory peptide by using squid liver protein
11/23/2011	CN102250993A Optimized process for producing enramycin through fermenting streptomyces
11/23/2011	CN102250992A High-efficiency expression of novel thrombus-resolving and anticoagulation double function fusion protein
11/23/2011	CN102250917A Method for preparing IL28B and special recombinant bacterium
11/23/2011	CN102250773A Scenedesmus as well as culturing method and application thereof
11/23/2011	CN102250292A 热塑性动物蛋白及其制备方法 Thermoplastic animal protein and its preparation method
11/23/2011	CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications
11/23/2011	CN102250233A Royal jelly polypeptide and application thereof
11/23/2011	CN102250225A Antimicrobial polyperptides from pseudoplectania nigrella
11/23/2011	CN102250215A Wheat antioxidant peptide and preparation method thereof
11/23/2011	CN101538318B Signal peptide, coding genes thereof and application
11/22/2011	US8065093 Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers
11/22/2011	US8063187 Methods and compositions for inhibiting CD32B expressing cells
11/22/2011	US8063186 Antibodies to PRO7436 polypeptides
11/22/2011	US8063181 Method for the production of cyclic molecules
11/22/2011	US8062996 Nucleotide sequences coding polypeptide for use in the detection of modulators and herbicides
11/22/2011	US8062892 Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/22/2011	US8062874 GFP fusion proteins and their use
11/22/2011	US8062867 Fusion partner for production of monoclonal rabbit antibodies
11/22/2011	US8062866 Humanized anti-IL-6 antibodies
11/22/2011	US8062865 Expression control using antibody expression optimisation sequences
11/22/2011	US8062864 Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
11/22/2011	US8062863 Nucleic acids encoding hamster 1GF-1 proteins and methods thereof
11/22/2011	US8062862 Hydrolysed egg proteins
11/22/2011	US8062640 High affinity human antibodies to PCSK9
11/22/2011	CA2474106C A process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
11/22/2011	CA2430013C Transgenic transchromosomal rodents for making human antibodies
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2344740C Mutant cholera holotoxin as an adjuvant
11/22/2011	CA2276534C Recombinant fusion proteins based on ribosome-inactivating proteins of the mistletoe viscum album
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/22/2011	CA2257826C Helicobacter pylori adhesin binding group antigen
11/17/2011	WO2011143562A2 Il-1 binding proteins
11/17/2011	WO2011143383A2 Protease catalyzed in situ end capping of oligopeptides in aqueous media
11/17/2011	WO2011143318A2 Anti-fgfr2 antibodies
11/17/2011	WO2011142461A1 Antibody for diagnosing amyotrophic lateral sclerosis (als)
11/17/2011	WO2011142019A1 Gene encoding lignan methyltransferase, and use thereof
11/17/2011	WO2011089170A3 Process for preparing fgf-21 with low degree of o-glycosylation
11/17/2011	WO2011085095A3 Enhanced protein expression
11/17/2011	US20110283384 Plants and seeds of corn variety cv458809
11/17/2011	US20110283376 Methods of Modifying Eukaryotic Cells
11/17/2011	US20110282037 Antibody preparation
11/17/2011	US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281797 Site-specific monoconjugated insulinotropic glp-1 peptides
11/17/2011	US20110281789 Ulbp antibodies
11/17/2011	US20110281761 Multi-chain eukaryotic display vectors and uses thereof
11/17/2011	US20110281751 Cell surface display of polypeptide isoforms by stop codon readthrough
11/17/2011	US20110281360 Multi-chain eukaryotic display vectors and uses thereof
11/17/2011	US20110281330 Minicells expressing antibodies or derivatives thereof and comprising biologically active compounds
11/17/2011	US20110281302 Compositions and methods of treating disease with fgfr fusion proteins
11/17/2011	US20110281301 The secretory capacity in host cells
11/17/2011	US20110281300 Preparation method of recombinant protein by use of a fusion expression partner
11/17/2011	US20110281299 Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto
11/17/2011	US20110281286 Expression vector for establishing highly productive cell and the highly productive cell
11/17/2011	US20110281261 Vectors
11/17/2011	US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280888 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
11/17/2011	US20110280883 Fully human anti-epidermal growth factor receptor antibodies
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof

1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 1125